An Annotated Living Organoid Biobank for Studying Gallbladder Diseases and Drug Responses
- 5 February 2026
- journal article
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 71 (7) , 2833-2847
Abstract
Gallbladder cancer (GBC) while rare worldwide has a high prevalence in India. Pathogenesis is unclear and outcomes poor. No suitable models are available to study GBC pathogenesis and drug response. The aim of this study was to establish a biobank comprising patient derived organoids (PDOs) from a wide variety of gallbladder diseases including GBC and other rare pathologies. PDOs were developed from surgically resected gallbladders 15 normal; 58 inflamed; 12 xanthogranulomatous cholecystitis (XGC); 5 pre-invasive neoplasm (PIN); and 13 invasive malignant gallbladder pathologies. Marker expressions, functional activity, histological and gene expression analyses were performed to validate the models. Banked PDOs were retrieved and drug assays performed to assess line-specific responses. Protocol optimization achieved 58% (69/119) and 52% (10/19) success in organoid generation and expansion for all and invasive malignant pathologies, respectively-highest globally for GBC organoids reported to date. Organoids maintained tight junction integrity; P-gp pump and enzymatic activity; preserved tissue-specific gene and protein marker expression; histological features and genetic variations. Besides cryopreserved organoids from 62 patients, primary gallbladder tissue and high-quality DNA, RNA and protein derivatives have been banked. In gene expression analyses of tissue, XGC samples clustered with malignant subtypes, separate from benign pathologies. Derived XGC organoids showed a similar clustering. Enriched Hallmark pathways in XGC support neoplastic changes. Drug response assays demonstrate PDO line-specific response heterogeneity. The developed biobank of PDOs from different gallbladder pathologies provides a promising resource to study gallbladder diseases, investigate the pathogenesis of GBC and study drug responses.Keywords
All Related Versions
Funding Information
- Ministry of Education, India PhD Fellowship
- Wellcome-DBT India Alliance Margdarshi Fellowship (IA/M/12/500755)
- Tata Consultancy Services Foundation core grant
- Tata Trusts
This publication has 39 references indexed in Scilit:
- Characteristics and outcomes of gallbladder cancer patients at the Tata Medical Center, Kolkata 2017–2019Cancer Medicine, 2023
- Patient‐derived organoids for personalized gallbladder cancer modelling and drug screeningClinical and Translational Medicine, 2022
- Development of a system combining comprehensive genotyping and organoid cultures for identifying and testing genotype-oriented personalised medicine for pancreatobiliary cancersEuropean Journal of Cancer, 2021
- Oxidative Metabolism Drives Immortalization of Neural Stem Cells during TumorigenesisCell, 2020
- Establishment and Long-Term Culture of Organoids Derived from Human Biliary Tract CarcinomaSTAR Protocols, 2020
- Tumor Cell Biodiversity Drives Microenvironmental Reprogramming in Liver CancerCancer Cell, 2019
- Establishment of Patient-Derived Organoids and Drug Screening for Biliary Tract CarcinomaCell Reports, 2019
- Fibroblast growth factor receptor 4 promotes progression and correlates to poor prognosis in cholangiocarcinomaBiochemical and Biophysical Research Communications, 2014
- MYC on the Path to CancerCell, 2012
- The catalog of human cytokeratins: Patterns of expression in normal epithelia, tumors and cultured cellsCell, 1982